Home › Funds › JW Asset Management, LLC › TVTX

JW Asset Management, LLC position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

JW Asset Management, LLC reported holding 45,000 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 1.11% of its reported portfolio and ranking #13 among its reported holdings. JW Asset Management, LLC has disclosed TVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)45.00K sh
Reported value held$2.65M
Portfolio Weight1.11%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JW Asset Management, LLC's TVTX position evolved

JW Asset Management, LLC first disclosed a stake in TVTX in Q2 2026 at 30,000 shares (US$1.7M). The position peaked in Q3 2026 at 45,000 shares, worth US$2.6M. Across 2 filings, JW Asset Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 45,000 shares valued at US$2.6M — an increase of 15,000 shares quarter over quarter.. Notable position changes include a 50% increase in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 30.00K $1.70M New
Q3 2026 45.00K $2.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has JW Asset Management, LLC held TVTX?

JW Asset Management, LLC has disclosed TVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is JW Asset Management, LLC's current position in TVTX?

As of Q3 2026, JW Asset Management, LLC holds 45.00K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $2.65M, representing 1.11% of its reported portfolio and ranking #13.

Has JW Asset Management, LLC been buying or selling TVTX?

In the latest 13F filing (Q3 2026), JW Asset Management, LLC increased its position in TVTX. The position peaked in Q3 2026 at 45.00K shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.